Akira Murakami Selected Research

Akira Murakami Research Topics

Disease

52	Neoplasms (Cancer) 06/2020 - 01/2000
29	Carcinogenesis 12/2015 - 01/2000
27	Inflammation (Inflammations) 01/2021 - 05/2002
15	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 10/2021 - 06/2004
14	Colitis 07/2021 - 10/2003
13	Dry Eye Syndromes (Dry Eye Syndrome) 07/2022 - 10/2007
10	Cataract (Cataracts) 08/2022 - 11/2010
10	Hereditary Corneal Dystrophies 09/2010 - 11/2002
9	Colonic Neoplasms (Colon Cancer) 08/2014 - 01/2004
7	Body Weight (Weight, Body) 05/2012 - 01/2002
7	Open-Angle Glaucoma (Glaucoma, Open Angle) 02/2011 - 01/2006
6	Wounds and Injuries (Trauma) 10/2017 - 12/2005
6	Glaucoma 12/2015 - 12/2004
6	Carcinoma (Carcinomatosis) 09/2010 - 07/2002
5	Colorectal Neoplasms (Colorectal Cancer) 08/2014 - 10/2002
5	Breast Neoplasms (Breast Cancer) 01/2013 - 01/2007
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2021 - 07/2007
4	Hepatocellular Carcinoma (Hepatoma) 02/2021 - 08/2005
4	Retinitis Pigmentosa (Pigmentary Retinopathy) 11/2019 - 03/2011
4	Macular Edema 01/2018 - 01/2014
4	Pain (Aches) 10/2017 - 03/2009
4	Multiple Myeloma 01/2013 - 05/2005
4	Leukemia 01/2007 - 02/2003
3	Seasonal Allergic Rhinitis (Hay Fever) 07/2022 - 01/2020
3	Hypersensitivity (Allergy) 07/2022 - 01/2010
3	Ulcerative Colitis 03/2022 - 10/2003
3	Schizophrenia (Dementia Praecox) 03/2021 - 01/2020
3	Mental Disorders (Mental Disorder) 03/2021 - 01/2020
3	Obesity 09/2019 - 01/2010
3	Low Tension Glaucoma 01/2019 - 12/2007
3	Adenocarcinoma 01/2009 - 01/2004
3	Atherosclerosis 04/2007 - 05/2006
3	Neoplasm Metastasis (Metastasis) 09/2005 - 02/2005

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2002
16	zerumboneIBA 11/2021 - 05/2002
11	Messenger RNA (mRNA)IBA 11/2021 - 02/2005
11	Dextran SulfateIBA 07/2021 - 02/2005
11	CytokinesIBA 12/2015 - 01/2004
11	PhytochemicalsIBA 01/2015 - 01/2000
11	EnzymesIBA 01/2015 - 07/2004
11	SesquiterpenesIBA 01/2015 - 05/2002
10	AntioxidantsIBA 09/2014 - 03/2003
9	Ophthalmic Solutions (Eye Drops)IBA 08/2022 - 09/2009
9	Retinaldehyde (Retinal)IBA 01/2021 - 11/2010
9	auraptenIBA 07/2012 - 05/2002
7	TeaIBA 09/2014 - 09/2005
7	LigandsIBA 01/2013 - 10/2003
7	nobiletinIBA 01/2010 - 10/2002
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 10/2003
6	Biological ProductsIBA 05/2013 - 02/2003
6	DNA (Deoxyribonucleic Acid)IBA 03/2011 - 10/2002
6	AzoxymethaneIBA 01/2010 - 01/2004
6	NF-kappa B (NF-kB)IBA 02/2009 - 05/2005
6	1'-acetoxychavicol acetateIBA 01/2009 - 02/2002
6	Transforming Growth Factor beta (TGF-beta)IBA 05/2008 - 05/2003
5	Drinking WaterIBA 07/2021 - 10/2003
5	Fluorescein (Funduscein)FDA LinkGeneric 11/2019 - 05/2009
5	InterleukinsIBA 08/2015 - 02/2004
5	PolyphenolsIBA 09/2014 - 09/2005
5	Phorbol EstersIBA 01/2011 - 06/2002
5	CarcinogensIBA 01/2010 - 09/2002
5	Matrix Metalloproteinases (MMPs)IBA 10/2007 - 02/2005
4	Dextrans (Dextran)FDA Link 07/2021 - 10/2003
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 07/2021 - 10/2003
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2014 - 11/2011
4	FlavonoidsIBA 01/2011 - 01/2002
3	AllergensIBA 10/2021 - 02/2009
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 10/2003
3	MicroRNAs (MicroRNA)IBA 06/2020 - 12/2015
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2017 - 04/2006
3	retinol palmitate (retinyl palmitate)FDA Link 01/2017 - 01/2012
3	Interleukin-33IBA 08/2015 - 10/2009
3	Thymic Stromal LymphopoietinIBA 08/2015 - 01/2010
3	Therapeutic UsesIBA 11/2013 - 06/2009
3	cardamoninIBA 01/2013 - 08/2011
3	Interleukin-6 (Interleukin 6)IBA 11/2011 - 11/2005
3	Pharmaceutical PreparationsIBA 03/2011 - 07/2004
3	Protein Kinases (Protein Kinase)IBA 01/2011 - 05/2008
3	aplysiatoxinIBA 01/2011 - 06/2009
3	QuercetinIBA 01/2010 - 02/2005
3	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 02/2009 - 04/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2009 - 10/2005
3	Superoxides (Superoxide)IBA 10/2007 - 05/2002
3	Matrix Metalloproteinase 7 (Matrilysin)IBA 10/2007 - 02/2005
3	Scavenger Receptors (Scavenger Receptor)IBA 04/2007 - 05/2006
3	oxidized low density lipoproteinIBA 04/2007 - 05/2006
3	LDL Lipoproteins (beta Lipoproteins)IBA 04/2007 - 05/2006
3	LipopolysaccharidesIBA 04/2006 - 02/2003
3	Free RadicalsIBA 04/2006 - 05/2002
3	Chymases (Chymase)IBA 12/2005 - 06/2004
2	SolutionsIBA 08/2022 - 11/2020
2	diquafosolIBA 08/2022 - 01/2022

Therapy/Procedure

9	Therapeutics 06/2020 - 01/2003
7	Contact Lenses 07/2022 - 03/2007
6	Lasers (Laser) 03/2021 - 09/2007
4	Light Coagulation 01/2018 - 01/2014
3	Topical Administration 08/2022 - 01/2021
3	Oral Administration 07/2021 - 01/2009
3	Corneal Transplantation (Keratoplasty) 11/2020 - 04/2006
3	Chemoprevention 02/2008 - 01/2000